Safe Use Initiative - Extramural Research

FDA Broad Agency Announcement for the Advanced Research and Development of Regulatory Science

The U.S. Food and Drug Administration has an open, continuing announcement to solicit research and development in support of regulatory science and innovation. The Safe Use Initiative welcomes proposals to this announcement which support its mission and goal.

Safe Use funds subsection 8.5.1 of the BAA: Studies that develop innovative methods to create, facilitate and encourage research in the area of safe medication use that seeks to reduce preventable harm from drugs
  1. Nurse Pain Educator Pilot Program (NPE) – NEMA Research, Inc.
  2. FDA Health Care Professional Communication Project – Summer Productions  
  3. Integrated Clinical Decision Support System to Advance the Safe Use of Antibiotics – AZCERT, Inc.
  4. Pragmatic Risk Score for Severe Hypoglycemic Events – Kaiser Foundation Research Institute
  5. Optimizing the Use of Opioids Following Surgery – Kaiser Foundation Research Institute and Kaiser Permanente Northwest Center for Health Research
  6. Safe Stimulant Medication Prescribing for Adult ADHD – American Academy of Family Physicians (AAFP)
  7. Appearance and Performance Enhancing Substances Simulated Conversation for Health Professionals – The American Academy of Pediatrics (AAP)
  8. A Community Based Study of Adverse Effects of NSAIDS on the Kidney and Risk Mitigation to Reduce Preventable Harm – Albany College of Pharmacy and Health Sciences
  9. High-Alert Medication Safety Self-Assessment for Hospitals and Targeted Risk Reduction Tool Development – Institute for Safe Medication Practices (ISMP) 
  10. National Standardization of Intravenous (IV) and Oral Liquid Medications – American Society of Health-System Pharmacists (ASHP)
  11. Identifying Best Practices for the Safe Use of Pediatric Cough and Cold Medications – New York University
  12. Educational Resource for the Effective Communication Between Health Care Professionals and Patients About Impairing Risks of Prescribed Medication in Relation to Driving – Traffic Injury Research Foundation (TIRF)
  13. Real-time Risk Stratification for Hypo- or Hyperglycemia to Enhance Glucose Management Outcomes in Hospitals – University of Florida


Contact FDA

Safe Use Initiative Team

Professional Affairs and Stakeholder Engagement (PASE)

Office of the Center Director

WO 51-2341

10903 New Hampshire Avenue

Silver Spring, MD 20993

Page Last Updated: 08/19/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English